PROF Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 20:03):

Stats
Dagens volum	52 505.00
Gjennomsnittsvolum	35 624.00
Markedsverdi	188.10M
EPS	$0 ( 2024-03-07 )
Neste inntjeningsdato	( $-0.310 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.70
ATR14	$0.0980 (1.27%)

Insider Trading

Date	Person	Action	Amount	type
2012-12-20	Hofer Michael	Sell	40 000	Patriot Minefinders Inc.
2012-12-18	Hofer Michael	Sell	40 000	Patriot Minefinders Inc.
2012-06-19	Tejada Fred	Buy	500 000	Common Shares
2012-06-19	Blanchet Justin	Buy	500 000	Common Shares
2012-06-19	Schweitzer John H.	Buy	500 000	Common Shares

INSIDER POWER
0.00
Last 8 transactions
Buy: 3 000 000 \| Sell: 80 000

Volum Korrelasjon

Lang: -0.11 (neutral)

Kort: 0.10 (neutral)

Signal:(45.339) Neutral

Profound Medical Corp Korrelasjon

10 Mest positive korrelasjoner
MOMO	0.966
IMVT	0.958
BRAC	0.957
GLRE	0.957
FXCO	0.956
FMIV	0.955
MLCO	0.954
CBAY	0.953
ALXN	0.951
AVAC	0.951

10 Mest negative korrelasjoner
PIII	-0.958
APOP	-0.953
SNPX	-0.949
GRIN	-0.947
CREG	-0.947
SWAV	-0.946
UTME	-0.945
OP	-0.944
SMIT	-0.944
LGMK	-0.941

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Profound Medical Corp Korrelasjon - Valuta/Råvare

-0.09
( neutral )

-0.19
( neutral )

0.00
( neutral )

-0.22
( neutral )

0.07
( neutral )

0.09
( neutral )

Profound Medical Corp Økonomi

Annual	2023
Omsetning:	$7.33M
Bruttogevinst:	$4.46M (60.87 %)
EPS:	$-1.370

FY	2023
Omsetning:	$7.33M
Bruttogevinst:	$4.46M (60.87 %)
EPS:	$-1.370

FY	2022
Omsetning:	$6.68M
Bruttogevinst:	$3.02M (45.22 %)
EPS:	$-1.380

FY	2021
Omsetning:	$6.87M
Bruttogevinst:	$2.95M (42.95 %)
EPS:	$-1.500

Financial Reports:

No articles found.

Profound Medical Corp

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.